Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis.
| Image |  |
|---|---|
| Description | scientific article published on March 1994 |
| Author/s |
author: Gianni Boris Bradač |
| Publication date | March 1, 1994 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |